Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients

COVID-19, the illness caused by infection with the novel coronavirus SARS-CoV-2, is a rapidly spreading global pandemic in urgent need of effective treatments. Here we present a comprehensive examination of the host- and virus-targeted functions of the flavonolignan silibinin, a potential drug candi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch-Barrera, Joaquim, Martin-Castillo, Begoña, Buxó, Maria, Brunet, Joan, Encinar, José Antonio, Menendez, Javier A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356916/
https://www.ncbi.nlm.nih.gov/pubmed/32517353
http://dx.doi.org/10.3390/jcm9061770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356916/
https://www.ncbi.nlm.nih.gov/pubmed/32517353
http://dx.doi.org/10.3390/jcm9061770

Ejemplares similares